康艾注射液对中晚期癌症患者生活质量的影响  

Impact of Kang'ai Injection on Life Quality of Cancer patient at late stage

作　　者：陈强松[1] 欧武[1] 黄伟章[1] 裴润琼 李传叶 

机构地区：[1]广西合浦县中医院肿瘤科

出　　处：《世界中医药》2011年第4期294-296,共3页World Chinese Medicine

摘　　要：目的:观察康艾注射液对中晚期癌症患者生活质量的影响。方法:将60例患者随机分成2组,治疗组30例应用康艾注射液联合化疗治疗,对照组30例单纯应用化疗对照比较。观察Karnofsky评分、体重变化、食欲、睡眠的状况。结果:2组疗效比较,治疗组与对照组总有效率(RR)分别为46.7%、36.7%(P>0.05)。2组疾病控制率(DCR)分别为86.7%、76.7%(P>0.05)。2组生活质量情况比较,食量不受化疗影响:治疗组30例中有20例(66.7%),对照组30例中有13例(43.3%)。睡眠改善:治疗组30例中有18例(60.0%),对照组30例中有10例(33.3%)(P<0.05)。体重:治疗组治疗后比治疗前增加(P<0.05)。Karnofsky评分治疗组治疗后比治疗前增加(P<0.05),且优于对照组(P<0.05)。结论:康艾注射液治疗中晚期癌症具有提高机体免疫力,保护骨髓,减轻化疗的反应,增加体重的作用,提高生活质量,延长生存期。Objective：To observe impact of Kang＇ai Injection on life quality of cancer patient at late stage.Methods：Sixty patients were randomized to treatment group （n=30） using Kang＇ai Injection plus chemotherapy,and control group （n=30） using chemotherapy alone.Observing parameters include Karnofsky scoring,weight changes,appetite and sleeping condition.Results：Total effective rates for treatment group and control group were 46.7% and 36.7% respectively （P〉0.05）;disease control rates were 86.7% and 76.7% （P〉0.05）.Appetite not affected by chemotherapy：treatment group 20 cases （66.7%）,control group 13 cases （43.3%）;sleeping improvement：treatment group 18 cases （60.0%）,control group 10 cases （33.3%）（P〈0.05）;Weight gained after treatment （P0.05）;Karnofsky scoring increased after treatment （P〈0.05） and better than control group （P〈0.05）.Conclusion：Kang＇ai Injection can enhance immunity of cancer patient at late stage,protect bone marrow,reduce reaction to chemotherapy,gain weight,raise life quality,and prolong survival time.

关 键 词：中晚期癌症/中医药疗法 康艾注射液 @生活质量 

分 类 号：R473.73[医药卫生—护理学]